biostudies-literatureFerrell BNCI NIH HHSNational Institutes of Health1077-1083https://www.ebi.ac.uk/biostudies/studies/S-EPMC9094428biostudies-literatureUnknown29(6)<h4>Objectives</h4>Patients with cancer who are at a transition to Phase I investigational treatments have been identified as an underserved population with regard to palliative care. This disease transition is often accompanied by spiritual and existential concerns. The study objective was to conduct a secondary analysis of data from a larger study testing a palliative care intervention. This paper reports the findings of this secondary focus on the spiritual needs of this population.<h4>Methods</h4>Patients (n = 479) were accrued to this study prior to initiating a Phase I clinical trial with data collected at baseline, and 4, 12, and 24 week follow-up.<h4>Results</h4>Qualitative data revealed that the transition to Phase 1 trial participation is a time of balancing hope for extended life with the reality of advancing disease. Quantitative results demonstrated increased spirituality over time in both religious- and non-religious-affiliated patients.<h4>Conclusions</h4>Patients entering Phase I trials have important spiritual needs as they face treatment decisions, advancing disease, and often mortality. Spiritual care should be provided to seriously ill patients as a component of quality care.Psycho-oncologySpirituality in cancer patients on phase 1 clinical trials.PMC9094428NCI-R01 CA177562P30 CA033572City of Hope Core, NCI P30CA033572R01 CA177562Azad NSChung VFerrell BRuel NHCooper RSBorneman TKoczywas MSmith TJIrish TLfalseSpirituality in cancer patients on phase 1 clinical trials.<h4>Objectives</h4>Patients with cancer who are at a transition to Phase I investigational treatments have been identified as an underserved population with regard to palliative care. This disease transition is often accompanied by spiritual and existential concerns. The study objective was to conduct a secondary analysis of data from a larger study testing a palliative care intervention. This paper reports the findings of this secondary focus on the spiritual needs of this population.<h4>Methods</h4>Patients (n = 479) were accrued to this study prior to initiating a Phase I clinical trial with data collected at baseline, and 4, 12, and 24 week follow-up.<h4>Results</h4>Qualitative data revealed that the transition to Phase 1 trial participation is a time of balancing hope for extended life with the reality of advancing disease. Quantitative results demonstrated increased spirituality over time in both religious- and non-religious-affiliated patients.<h4>Conclusions</h4>Patients entering Phase I trials have important spiritual needs as they face treatment decisions, advancing disease, and often mortality. Spiritual care should be provided to seriously ill patients as a component of quality care.2020-01-01T00:00:00Z2020 Jun2025-04-04T23:34:21.437Z2025-04-04T23:34:21.437ZS-EPMC90944283222738210.1002/pon.5380